A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
Clinical trial NCT00249223 · COMPLETED
Trial details
- NCT number
- NCT00249223
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-01-01
- Enrollment
- 641
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.